Diabetics we need your help. We’re trying to understand the insulin market better. In particular we want to know more about customer loyalty to a particular brand or type of insulin.
Here’s what we gather from reading up on the matter. We’d love for you to let us know about any holes in the theory.
From what we’ve read, it’s a pain to establish an ideal insulin regime for diabetics. It involves numerous trips to the GP/specialist and trial and error to get everything optimised. And because competing and generic products are only bio-similar rather than identical, switching brands is something of a pain. It takes recommitting to another round of trial-and-error.
Partly resulting from this, there’s significant customer loyalty. As long as the diabetes is well controlled and as long as insurers continue to support a program, not a great deal of switching goes on. The only time most diabetics will even consider switching insulin brands is when the old regime ceases to be effective and needs to be changed anyway.
Is that broadly right? Have you ever switched insulin types/brands? How many times? Why? Was cost ever a deciding factor or was it because the previous regime stopped working effectively? And what was the process involved?
Thank you in advance for anything you can do to further our understanding of the topic.
Ready to invest?
Visit this page for more information on how to invest with Forager.
Forager Funds is a boutique fund manager specialising in a value investing approach. We offer an ASX listed Australian Shares Fund as well as an International Shares Fund both aimed at delivering returns for long term investors.